뉴스
-
Biotech Stocks Rally Despite Peptron, HLB Shocks[K-Bio Pulse]
Peptron and HLB Group companies plunged to their daily lower limits on July 10 amid separate setbacks. Despite the sharp selloffs, buying momentum spread across
www.edaily.co.kr · 2026.07.11
-
Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse]
The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended
www.edaily.co.kr · 2026.07.14
-
HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains
www.edaily.co.kr · 2026.07.16
-
HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse]
On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, busines
www.edaily.co.kr · 2026.06.17
